Haleon, the U.S.-based unit of the U.K.-based global consumer health company, has issued a voluntary recall of eight lots of the popular cough syrup Robitussin due to microbial contamination, according to an advisory by the US Food and Drug Administration (FDA). The tainted products in question are the Robitussin Honey CF Max Day and Nighttime, which are commonly used to alleviate symptoms associated with cold, flu, hay fever, and other respiratory allergies.
The FDA has warned that the use of these contaminated products could lead to "severe or life-threatening adverse events" in individuals with compromised immune systems. The potential complications include fungemia, which refers to the presence of fungus or yeasts in the blood, as well as disseminated fungal infection. While non-immunocompromised individuals are unlikely to experience adverse effects, the advisory states that the occurrence of an infection that may require medical intervention cannot be completely ruled out.
To prevent further contamination, Haleon is urging customers who have purchased the affected cough syrup to immediately stop consumption. They are also advising clients to contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product. Adverse reactions or other issues pertaining to the product can be reported to the FDA's MedWatch Adverse Event Reporting program either online, via regular mail, or by fax.
So far, Haleon has not received any reports of symptoms stemming from this recall. However, the company is taking proactive measures to address the issue and has issued a voluntary recall of two specific Robitussin cough medicines. The recalled products are Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult. Haleon has notified its distributors and customers directly to return the recalled products.
The recall of these eight lots of Robitussin cough syrup is being conducted with the knowledge of the U.S. FDA. Haleon emphasizes that the safety and well-being of its customers are its top priorities. The company is working diligently to address the issue and ensure that all necessary steps are taken to prevent any further harm.
Consumers who have purchased the recalled products are strongly advised not to use them. Haleon has provided a helpline for customers with questions, which can be reached at (800) 245-1040 from Monday to Friday, between 8 a.m. and 6 p.m. Eastern time. Alternatively, customers can also contact the company via email at mystory.us@haleon.com.
This recall serves as a reminder of the importance of product safety and the need for prompt action when potential risks are identified. It is crucial for consumers to stay informed about product recalls and take appropriate measures to protect their health and well-being.
